December 19th 2022
Jennifer Roggenbuck, MS, CGC, navigates the testing, diagnosis, and management of patients with ALS.
December 8th 2022
Key opinion leaders discuss the landscape surrounding multi-drug resistant (MDR) therapies for patients with HIV.
August 15th 2022
Three experts discuss the impact of digital therapeutics (DTx) and prescription digital therapeutics (PDTs) as behavioral health therapy, from benefits to the treatment space to potential improvements and unmet needs.
February 21st 2022
Two experts discuss uterine fibroids and treating the disease as both a provider and payer.
December 23rd 2021
Discussion on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
November 19th 2021
A payer and community physician raise attention to limitations surrounding measures for screening and treating atopic dermatitis.
July 1st 2021
A discussion on the clinical and managed care considerations of wet AMD treatment, including the varying approaches to disease management.
March 30th 2021
March 26th 2021
Multiple sclerosis (MS) is a chronic disease that involves demyelination of plaque throughout the white and gray matter of the central nervous system. The early stages of MS are usually marked by a relapsing-remitting course of neurological deficits, which progress toward continuous, permanent dysfunction and disability. Of those with a diagnosis of MS, 74% are women.